Capsular Localization of the Cryptococcus neoformans Polysaccharide Component Galactoxylomannan

被引:45
作者
De Jesus, Magdia [1 ]
Nicola, Andre Moraes [1 ]
Rodrigues, Marcio L. [2 ]
Janbon, Guilhem [3 ]
Casadevall, Arturo [1 ]
机构
[1] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA
[2] Univ Fed Rio de Janeiro, Inst Microbiol Prof Paulo de Goes, Lab Estudos Integrados Bioquim Microbiana, BR-21941590 Rio De Janeiro, Brazil
[3] Inst Pasteur, CNRS, Unite Mycol Mol, URA3012, F-75015 Paris, France
关键词
MONOCLONAL-ANTIBODIES; SEROTYPE-A; GLUCURONOXYLOMANNAN; IMMUNOGENICITY; APOPTOSIS; VIRULENCE; LECTIN; GENES; YEAST; AIDS;
D O I
10.1128/EC.00331-08
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Cryptococcus neoformans capsular polysaccharide is composed of at least two components, glucuronoxylomannan (GXM) and galactoxylomannans (GalXM). Although GXM has been extensively studied, little is known about the location of GalXM in the C. neoformans capsule, in part because there are no serological reagents specific to this antigen. To circumvent the poor immunogenicity of GalXM, this antigen was conjugated to protective antigen from Bacillus anthracis as a protein carrier. The resulting conjugate elicited antibodies that reacted with GalXM in mice and yielded an immune serum that proved useful for studying GalXM in the polysaccharide capsule. In acapsular cells, immune serum localized GalXM to the cell wall. In capsulated cells, immune serum localized GalXM to discrete pockets near the capsule edge. GalXM was abundant on the nascent capsules of budding daughter cells. The constituent sugars of GalXM were found in vesicle fractions consistent with vesicular transport for this polysaccharide. In addition, we generated a single-chain fraction variable fragment antibody with specificity to oxidized carbohydrates that also produced punctate immunofluorescence on encapsulated cells that partially colocalized with GalXM. The results are interpreted to mean that GalXM is a transient component of the polysaccharide capsule of mature cells during the process of secretion. Hence, the function of GalXM appears to be more consistent with that of an exopolysaccharide than a structural component of the cryptococcal capsule.
引用
收藏
页码:96 / 103
页数:8
相关论文
共 34 条
[11]   CRYPTOCOCCUS-NEOFORMANS SEROTYPE-A GLUCURONOXYLOMANNAN-PROTEIN CONJUGATE VACCINES - SYNTHESIS, CHARACTERIZATION, AND IMMUNOGENICITY [J].
DEVI, SJN ;
SCHNEERSON, R ;
EGAN, W ;
ULRICH, TJ ;
BRYLA, D ;
ROBBINS, JB ;
BENNETT, JE .
INFECTION AND IMMUNITY, 1991, 59 (10) :3700-3707
[12]  
DUBOIS M, 1956, ANAL CHEM, V28, P356, DOI DOI 10.1021/AC60111A017
[13]   PRODUCTION AND CHARACTERIZATION OF MONOCLONAL-ANTIBODIES SPECIFIC FOR CRYPTOCOCCUS-NEOFORMANS CAPSULAR POLYSACCHARIDE [J].
ECKERT, TF ;
KOZEL, TR .
INFECTION AND IMMUNITY, 1987, 55 (08) :1895-1899
[14]  
GOREN MB, 1967, J IMMUNOL, V98, P914
[15]   ANTIGENIC CHARACTERIZATION OF CRYPTOCOCCUS-NEOFORMANS SEROTYPES AND ITS APPLICATION TO SEROTYPING OF CLINICAL ISOLATES [J].
IKEDA, R ;
SHINODA, T ;
FUKAZAWA, Y ;
KAUFMAN, L .
JOURNAL OF CLINICAL MICROBIOLOGY, 1982, 16 (01) :22-29
[16]   GALACTOXYLOMANNANS OF CRYPTOCOCCUS-NEOFORMANS [J].
JAMES, PG ;
CHERNIAK, R .
INFECTION AND IMMUNITY, 1992, 60 (03) :1084-1088
[17]   The molecular basis for the immunogenicity of Cryptococcus neoformans mannoproteins [J].
Levitz, Stuart M. ;
Specht, Charles A. .
FEMS YEAST RESEARCH, 2006, 6 (04) :513-524
[18]   Prevalence of clinical isolates of Cryptococcus gattii serotype C among patients with AIDS in sub-Saharan Africa [J].
Litvintseva, AP ;
Thakur, R ;
Reller, LB ;
Mitchell, TG .
JOURNAL OF INFECTIOUS DISEASES, 2005, 192 (05) :888-892
[19]   Radial mass density, charge, and epitope distribution in the Cryptococcus neoformans capsule [J].
Maxson, Michelle E. ;
Dadachova, Ekaterina ;
Casadevall, Arturo ;
Zaragoza, Oscar .
EUKARYOTIC CELL, 2007, 6 (01) :95-109
[20]   The physical properties of the capsular polysaccharides from Cryptococcus neoformans suggest features for capsule construction [J].
McFadden, DC ;
De Jesus, M ;
Casadevall, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (04) :1868-1875